Need professional-grade analysis? Visit stockanalysis.com
$134.38B
21.92
3,966
0.17%
Caplin Point Laboratories Limited (CAPLIPOINT) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1770.90, up 0.34% from the previous close.
Over the past year, CAPLIPOINT has traded between a low of INR1504.80 and a high of INR2343.00. The stock has lost 6.0% over this period. It is currently 24.4% below its 52-week high.
Caplin Point Laboratories Limited has a market capitalization of $134.38B, with a price-to-earnings ratio of 21.92 and a dividend yield of 0.17%.
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Side-by-side comparison against top Healthcare peers.